Health-Related Quality-of-Life Analysis From KEYNOTE-045: A Phase III Study of Pembrolizumab Versus Chemotherapy for Previously Treated Advanced Urothelial Cancer
Articolo
Data di Pubblicazione:
2018
Citazione:
Health-Related Quality-of-Life Analysis From KEYNOTE-045: A Phase III Study of Pembrolizumab Versus Chemotherapy for Previously Treated Advanced Urothelial Cancer / Vaughn, D.j., Bellmunt, J., Fradet, Y., Lee, J.l., Fong, L., Vogelzang, N.j., Climent, M.a., Petrylak, D.p., Choueiri, T.k., Necchi, A., Gerritsen, W., Gurney, H., Quinn, D.i., Culine, S., Sternberg, C.n., Mai, Y.b., Li, H.j., Perini, R.f., Bajorin, D.f., de Wit, R.. - In: JOURNAL OF CLINICAL ONCOLOGY. - ISSN 0732-183X. - 36:16(2018), pp. 1579-+. [10.1200/JCO.2017.76.9562]
Tipologia CRIS:
1.1 Articolo in rivista
Elenco autori:
Vaughn, Dj; Bellmunt, J; Fradet, Y; Lee, Jl; Fong, L; Vogelzang, Nj; Climent, Ma; Petrylak, Dp; Choueiri, Tk; Necchi, A; Gerritsen, W; Gurney, H; Quinn, Di; Culine, S; Sternberg, Cn; Mai, Yb; Li, Hj; Perini, Rf; Bajorin, Df; de Wit, R
Link alla scheda completa:
Pubblicato in: